Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127034661 | 12703466 | 1 | I | 2016 | 20160821 | 20160831 | 20160831 | PER | US-PFIZER INC-2016397544 | PFIZER | 67.00 | YR | F | Y | 94.00000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127034661 | 12703466 | 1 | PS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Vaginal | 0.5 MG, 2X/WEEK | N | 20216 | .5 | MG | VAGINAL CREAM | BIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127034661 | 12703466 | 1 | Hormone level abnormal |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127034661 | 12703466 | Abdominal pain | |
| 127034661 | 12703466 | Headache | |
| 127034661 | 12703466 | Malaise | |
| 127034661 | 12703466 | Nausea | |
| 127034661 | 12703466 | Product use issue | |
| 127034661 | 12703466 | Vomiting | |
| 127034661 | 12703466 | Vulvovaginal mycotic infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127034661 | 12703466 | 1 | 2016 | 0 |